Literature DB >> 8199113

Prevalence of blindness and low vision of people over 30 years in the Wenchi district, Ghana, in relation to eye care programmes.

A C Moll1, A J van der Linden, M Hogeweg, W E Schader, J Hermans, R J de Keizer.   

Abstract

A population based survey on the prevalence of major blinding disorders was conducted in the Wenchi district in central Ghana between March and May 1991. In 10 villages, 1425 people of 30 years and older were screened, using the WHO eye examination record. The prevalence of bilateral blindness above 30 years proved to be 1.7% (best acuity < 3/60): the prevalence of low vision above 30 years was 2.0% (best visual acuity 6/18 to 3/60). The causes of blindness were determined as cataract (62.5%), onchocerciasis (12.5%), corneal opacity (non-trachomatous) (8.2%), refraction anomalies (4.2%), phthisis bulbi (4.2%), optic atrophy (4.2%), and vascular retinopathy (4.2%). In the Wenchi district, 1.0% of the population over the age of 30 years was found to need a cataract extraction because of blindness of both eyes. Another potential 1.0% needs a cataract extraction because of low vision. A minor second study (n = 149) was undertaken in the same district, but in a village in an area near the Black Volta river in which onchocerciasis is endemic. The prevalence of blindness (8.1%) and low vision (3.4%) caused by onchocerciasis and cataract both proved to be higher. The survey provided the basis for a preventive and curative eye care programme.

Entities:  

Mesh:

Year:  1994        PMID: 8199113      PMCID: PMC504762          DOI: 10.1136/bjo.78.4.275

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  20 in total

1.  Prevalence and causes of vision loss in central Tanzania.

Authors:  P A Rapoza; S K West; S J Katala; H R Taylor
Journal:  Int Ophthalmol       Date:  1991-03       Impact factor: 2.031

2.  Ocular onchocerciasis.

Authors:  J W R SARKIES
Journal:  Br J Ophthalmol       Date:  1952-02       Impact factor: 4.638

3.  Effects of repeated doses of ivermectin on ocular onchocerciasis: community-based trial in Sierra Leone.

Authors:  J A Whitworth; C E Gilbert; D M Mabey; G H Maude; D Morgan; D W Taylor
Journal:  Lancet       Date:  1991-11-02       Impact factor: 79.321

4.  Ocular manifestations of onchocerciasis in a rain forest area of west Africa.

Authors:  H S Newland; A T White; B M Greene; R P Murphy; H R Taylor
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

5.  Who will operate on Africa's 3 million curably blind people?

Authors:  A Foster
Journal:  Lancet       Date:  1991-05-25       Impact factor: 79.321

Review 6.  Xerophthalmia, keratomalacia and nutritional blindness.

Authors:  A Sommer
Journal:  Int Ophthalmol       Date:  1990-05       Impact factor: 2.031

Review 7.  Trachoma.

Authors:  H R Taylor
Journal:  Int Ophthalmol       Date:  1990-05       Impact factor: 2.031

8.  Causes and prevalence of blindness in the Northern Province of Sierra Leone.

Authors:  J S Stilma; S Bridger
Journal:  Doc Ophthalmol       Date:  1983-12-15       Impact factor: 2.379

9.  Prevalence and aetiology of cataract in Punjab.

Authors:  A Chatterjee; R C Milton; S Thyle
Journal:  Br J Ophthalmol       Date:  1982-01       Impact factor: 4.638

10.  Blindness and eye disease in Kenya: ocular status survey results from the Kenya Rural Blindness Prevention Project.

Authors:  R Whitfield; L Schwab; D Ross-Degnan; P Steinkuller; J Swartwood
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

View more
  13 in total

Review 1.  Blindness in Africa: present situation and future needs.

Authors:  S Lewallen; P Courtright
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

2.  Prevalence and causes of blindness and visual impairment in Muyuka: a rural health district in South West Province, Cameroon.

Authors:  J E Oye; H Kuper; B Dineen; R Befidi-Mengue; A Foster
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

3.  Survey of blindness and visual impairment in Bioko, Equatorial Guinea.

Authors:  C L Moser; M Martín-Baranera; F Vega; V Draper; J Gutiérrez; J Mas
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

4.  Prevalence of blindness in people over 40 years in the volta region of ghana.

Authors:  J P Guzek; F K Anyomi; S Fiadoyor; F Nyonator
Journal:  Ghana Med J       Date:  2005-06

5.  Blindness and visual impairment in an urban West African population: the Tema Eye Survey.

Authors:  Donald L Budenz; Jagadeesh R Bandi; Keith Barton; Winifred Nolan; Leon Herndon; Julia Whiteside-de Vos; Graham Hay-Smith; Hanna Kim; James Tielsch
Journal:  Ophthalmology       Date:  2012-06-05       Impact factor: 12.079

6.  [Ophthalmological screening via a hospital boat: field study for planning future health care services in remote villages at the Volta Lake in Ghana].

Authors:  A Frimpong-Boateng; F Rüfer; S Fiadoyor; J Nkrumah-Mills; F Mensah-Tetteh; N Kudoadzi; J Roider
Journal:  Ophthalmologe       Date:  2009-09       Impact factor: 1.059

7.  Causes of low vision and their management at Korle Bu Teaching Hospital, Accra, GHANA.

Authors:  E M Ackuaku-Dogbe; B Abaidoo; Z I Braimah; G Afenyo; S Asiedu
Journal:  J West Afr Coll Surg       Date:  2016 Jul-Sep

8.  Cataract Surgical Uptake Among Older Adults in Ghana.

Authors:  E M Ackuaku-Dogbe; A E Yawson; R B Biritwum
Journal:  Ghana Med J       Date:  2015-06

Review 9.  Epidemiology of glaucoma in sub-saharan Africa: prevalence, incidence and risk factors.

Authors:  Fatima Kyari; Mohammed M Abdull; Andrew Bastawrous; Clare E Gilbert; Hannah Faal
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Apr-Jun

10.  Self-reported cataracts in older adults in Ghana: sociodemographic and health related factors.

Authors:  Alfred E Yawson; Edith M Ackuaku-Dogbe; Nana A Hagan Seneadza; George Mensah; Nadia Minicuci; Nirmala Naidoo; Somnath Chatterji; Paul Kowal; Richard B Biritwum
Journal:  BMC Public Health       Date:  2014-09-12       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.